UK biotech and University of Birmingham in licensing deal for nasal spray targeting COVID-19 09-Nov-2021 By Jane Byrne Birmingham Biotech and the University of Birmingham have signed a licensing agreement for an anti-viral nasal spray against COVID-19.
Novel nasal spray reduces viral replication by up to 96%: according to COVID-19 challenge study 28-Sep-2020 By Rachel Arthur Ena Respiratory’s preventative nasal spray treatment could reach human trials within four months, following results from an animal study released today which showed the spray reduced COVID-19 replication by up to 96%.
